Yervoynew

961,00 

Therapeutic CTLA4-antibody from the original commercial drug Yervoy targeting the CTLA4-antigen (CD152), also referred to as Iplimumab antibody. This antibody is available with the original certificate of analysis (CoA).

Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Storage [°C] Certificate of Analysis (CoA)* Original therapeutic expiry date Availability PriceQuantityTotal
54002ABE04682-8°/-80°yes08/2021ready to ship 961,00 
-
+
961,00 
spinner

Category: SKU: N/A

Description

Additional information

Weight N/A
Therapeutic molecule

Ipilimumab

Antigen

CD152, CTLA4

Product Concentration [mg/mL]

5

Volume per Vial [µL]

400

Quantity per vial [mg]

2

Batch Number

ABE0468

Storage [°C]

-, -80°, 2-8°/-80°

Certificate of Analysis (CoA)*

no, yes

Original therapeutic expiry date

08/2021

Availability

1 week after order, ready to ship

You may also like…